May 2, 2012 | Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology, Laboratory Sales and Marketing
Labs are facing new threats as managed care plans cut reimbursement levels and new companies are coming between labs and their physician clients
*** Revised Version – Original Version Misstated: The previous version had statements attributed to Ignis Systems that were incorrect. The corrected version is below.
DATELINE: NEW ORLEANS, LOUISIANA—It was a big opening for the 17th annual Executive War College (EWC) on Laboratory and Pathology Management yesterday. A record crowd of about 700 enthusiastic clinical laboratory managers and pathologists heard lab industry leaders predict a fast-changing future for the medical laboratory testing industry.
The editorial team from The Dark Report and Dark Daily are all here to cover the sessions and provide you with useful intelligence and insights about market trends and innovations in the management and operations of clinical laboratories. That was true of yesterday’s opening general session, followed by an afternoon of clinical laboratory management case studies.
(more…)
Apr 12, 2012 | Laboratory Operations, Laboratory Pathology, Management & Operations
Many challenges ahead for Rusckowski because of healthcare’s unfolding transformation
Yesterday, after the stock markets closed, Quest Diagnostics Incorporated (NYSE: DGX) issued a press release naming Stephen H. Rusckowski as its new President and CEO. He will assume his duties on May 1, 2012. Quest Diagnostics is the nation’s largest clinical laboratory company.
Along with the appointment of its new President and CEO, Quest Diagnostics also announced that Daniel C. Stanzione, Ph.D., would become the Non-Executive Chairman of the Board for the Madison, New Jersey-based company. Stanzione has served as a Director on the Quest Board since 2004.
To ensure an orderly transition, Surya N. Mohapatra, Ph.D., the current Chairman, President, and CEO, will continue his duties through April 30, 2012. It was on October 25, 2011, when Quest Diagnostics disclosed a succession plan and stated that Mohapatra, now 61 years old, would serve for an additional six months as the company conducted its search for another CEO.
(more…)
Nov 18, 2011 | Laboratory Management and Operations, Laboratory Operations, Laboratory Pathology
DATELINE: San Antonio, Texas—This week, a large and enthusiastic crowd of clinical laboratory managers and pathologists gathered here to participate in the fifth annual Lab Quality Confab, a conference devoted to Lean, Six Sigma, and process improvement in medical laboratories and hospitals.
It was an opportunity to judge the “state of the clinical laboratory testing industry” in regards to how quality management and the tools of Lean and continuous improvement are helping to transform the nation’s more innovative medical laboratory organizations. This is an important trend in laboratory medicine and it is still in its earliest stages.
(more…)
Nov 14, 2011 | Compliance, Legal, and Malpractice, Laboratory News, Laboratory Pathology, Laboratory Sales and Marketing
Two Senate committees seem interested in how certain medical laboratories offer discounted laboratory test prices to selected health insurers
Is it a coincidence that discounted medical laboratory test pricing offered by the nation’s two largest clinical laboratory companies appears to now be the subject of interest for the Senate Judiciary and Senate Finance Committees? Last Tuesday, Senator Max Baucus (D-Montana) and Senator Chuck Grassley (R-Iowa) issued a press release titled “Grassley, Baucus Scrutinize Practice by Health Insurers and Testing Labs.”
Baucus is Chairman of the Senate Finance Committee and Grassley is the Ranking Member of the Senate Judiciary Committee. Together, these two Senators sent letters last week to two clinical laboratory companies and three big health insurance firms: (more…)
Oct 12, 2011 | Laboratory News, Uncategorized
Deal may be just the first of more clinical laboratory acquisitions in the U.S by Japan’s largest medical lab testing company
Pathology and clinical laboratory testing companies continue to go global and last week’s big acquisition in anatomic pathology gave one of Japan’s biggest clinical laboratory companies an important foothold in the United States.
Miraca Holdings Inc. (TYO: 4544.T) of Tokyo, Japan, announced that it would acquire the anatomic pathology business of Caris Life Sciences, Inc., of Irving, Texas. Miraca says the purchase is the first ever by a Japanese company of a clinical laboratory testing company in the United States.
(more…)
